Compare APOG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APOG | ORGO |
|---|---|---|
| Founded | 1949 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.9M | 514.0M |
| IPO Year | 1994 | 2016 |
| Metric | APOG | ORGO |
|---|---|---|
| Price | $38.54 | $2.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $47.00 | $7.67 |
| AVG Volume (30 Days) | 146.4K | ★ 554.3K |
| Earning Date | 04-09-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 1.74 | 0.15 |
| Revenue | ★ $1,360,994,000.00 | $564,169,000.00 |
| Revenue This Year | $4.12 | N/A |
| Revenue Next Year | N/A | $10.07 |
| P/E Ratio | $22.63 | ★ $19.83 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $30.75 | $2.61 |
| 52 Week High | $48.79 | $7.08 |
| Indicator | APOG | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 25.18 |
| Support Level | $37.52 | $2.61 |
| Resistance Level | $38.52 | $3.28 |
| Average True Range (ATR) | 1.24 | 0.23 |
| MACD | -0.38 | -0.08 |
| Stochastic Oscillator | 17.08 | 4.14 |
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.